RO92640B1 - Method for treating viral keratoiditis - Google Patents

Method for treating viral keratoiditis

Info

Publication number
RO92640B1
RO92640B1 RO118715A RO11871585A RO92640B1 RO 92640 B1 RO92640 B1 RO 92640B1 RO 118715 A RO118715 A RO 118715A RO 11871585 A RO11871585 A RO 11871585A RO 92640 B1 RO92640 B1 RO 92640B1
Authority
RO
Romania
Prior art keywords
mepacrine
keratoiditis
treating viral
viral
iventia
Prior art date
Application number
RO118715A
Other languages
Romanian (ro)
Other versions
RO92640A2 (en
Inventor
Francisc Fodor
Ludovic Adam
Carol Csedo
Original Assignee
Francisc Fodor
Ludovic Adam
Carol Csedo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Francisc Fodor, Ludovic Adam, Carol Csedo filed Critical Francisc Fodor
Priority to RO85118715A priority Critical patent/RO92640A2/en
Publication of RO92640B1 publication Critical patent/RO92640B1/en
Publication of RO92640A2 publication Critical patent/RO92640A2/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Iventia se refera l ao metoda pentru tratamentul karatitelor virotice, utilizata în oftalmologoe. în scopul obtinerii unui efect terapeutic rapid, se fac instalatii în sacul conjunctival cu o solutie apoasa 1% mepacrina, pana la epitelizarea eroziunilor inflamatorii corneene si concomitent, în primele 24h, se administreaza oral mepacrina si 1..2 drajeuri de emetiral, pentru a preveni eventuale fenomene de inteleranta gastrica, iar în urmatoarele 3 zile, cate o tableta de mepacrina/zi pentru a îmbiedica eliminarea renala a substantei active si a asigura un efect prelungit al acesteia.Iventia refers to a method for the treatment of viral carrays, used in ophthalmology. In order to obtain a rapid therapeutic effect, devices are made in the conjunctival sac with a 1% aqueous solution of mepacrine until the epithelial corneal inflammatory erosions are achieved and concomitantly, in the first 24 hours, oral mepacrine and 1-2 emetiral tablets are administered to prevent any gastric intestinal phenomena, and within the next 3 days, one tablet of mepacrine / day to inhibit the renal elimination of the active substance and ensure its prolonged effect.

RO85118715A 1985-05-13 1985-05-13 METHOD FOR TREATMENT OF VIROTIC KERATITS RO92640A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RO85118715A RO92640A2 (en) 1985-05-13 1985-05-13 METHOD FOR TREATMENT OF VIROTIC KERATITS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO85118715A RO92640A2 (en) 1985-05-13 1985-05-13 METHOD FOR TREATMENT OF VIROTIC KERATITS

Publications (2)

Publication Number Publication Date
RO92640B1 true RO92640B1 (en) 1987-05-31
RO92640A2 RO92640A2 (en) 1987-09-30

Family

ID=20117170

Family Applications (1)

Application Number Title Priority Date Filing Date
RO85118715A RO92640A2 (en) 1985-05-13 1985-05-13 METHOD FOR TREATMENT OF VIROTIC KERATITS

Country Status (1)

Country Link
RO (1) RO92640A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7084157B2 (en) * 2002-05-17 2006-08-01 Rajeev Raut Ophthalmic pharmaceutical compositions and methods for treating ocular inflammation

Also Published As

Publication number Publication date
RO92640A2 (en) 1987-09-30

Similar Documents

Publication Publication Date Title
DK542279A (en) PHARMACEUTICAL PREPARATION CONTAINING A HEALTH-CONTROLLING GLYCOSIDE WITH A POLYMER COATING
DE69021214D1 (en) ORAL COMPOSITION FOR THE TREATMENT OF INTESTINAL FLAMMABLE DISEASES.
IL71506A (en) Rapid dissolving,uniform pharmaceutical compositions of low water solubility drugs and their preparation
IS1694B (en) Medicinal product for administration to oral animals containing proton pump blockers
MY100439A (en) Controlled release naproxen and naproxen sodium tablets
RU93036959A (en) FREE SOLUBLE MEDICATION WITH SLOW-UP ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES, ASSIGNED FOR RECEPTION INSIDE, THE METHOD OF ITS MANUFACTURE
DK342989A (en) Anti-inflammatory drug
IT1170214B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES
DK607885D0 (en) THE MEDICINAL PREPARATION WITH REDUCED TOXICITY
FR2439194A1 (en) DIBENZOTHIEPINE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
RO92640B1 (en) Method for treating viral keratoiditis
GB2092001B (en) Pharmaceutical preparations comprising sodium fructose-1,6-diphosposphate for treatment of burn patients
ATE82126T1 (en) PREPARATION TO STOP ANGIOGENESIS AND A CAPILLARY, CELL OR MEMBRANE LEAK.
ES8802612A1 (en) Benzisoselenazolonyl derivatives, process for their preparation and pharmaceutical compositions containing them.
GB1292496A (en) Dosage units of contraceptive preparations for human use
KR880010762A (en) Composition and Method for Treatment of peptic Ulcers
PH24977A (en) Therapeutic treatment of intestinal inflammation by administration of 3,4-dihydro-2h-1-benzopyran derivatives
ES8303915A1 (en) Pharmaceutical composition of phosphonomicin in tablet form.
IT8321358A1 (en) Derivatives with therapeutic activity of S-carboxymethylcysteine, process for their preparation and pharmaceutical compositions containing them
IT8321398A0 (en) PHARMACEUTICAL PREPARATIONS FOR TOPICAL TREATMENT OF CATARACT.
GB1254125A (en) Pharmaceutical composition suitable for the treatment of certain vascular diseases
IT1137144B (en) DERIVATIVES OF VINCAMIN AND INDOLIC ALCALOIDS RELATED TO THERAPEUTIC ACTIVITIES, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IT1227789B (en) THYOLIC DERIVATIVES OF Erythromycin FOR THERAPEUTIC ACTIVITY, RELATIVE PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
GB1409945A (en) Pharmaceutical preparations
IT1167538B (en) DREGAMINA DERIVATIVES, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR THERAPEUTIC USE